Avitide

Acquired

A new generation of purification technologies for biopharmaceutical manufacturing.

Lebanon, United States · Founded 2013 · $11.0M raised

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$11.0M
Last Round
$7.6M Series CAug 2015
Rounds
3
Acquired by
Repligen CorporationSep 2021

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Avitide is the industry's premier biopharmaceutical affinity purification partner. The company develops a proprietary portfolio of AVIPure™ affinity ligands and end-to-end purification platforms for novel drug modalities including gene therapies, viral vaccines, bispecific antibodies, and cell-based therapies. Avitide works with partners from concept through commercial resin supply, delivering improved purity, yield, and manufacturing economics—reducing cost of goods and accelerating development timelines for biologic manufacturers. Acquired by Repligen in 2021.

Summary

Avitide is a Biotech company based in Lebanon, United States, founded in 2013. It has raised $11.0M in total across 3 rounds, most recently a $7.6M Series C round in Aug 2015. Investors include Borealis Ventures, NeoMed Management and OrbiMed.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionSep 2021

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avitide on Indexed.vc
<a href="https://indexed.vc/companies/avitide"><img src="https://indexed.vc/api/badge/company/avitide" alt="Avitide on Indexed.vc" width="260" height="76" /></a>